Notable Labs (NTBL) Company Sales Volume

Corporate emblem and logo of notablelabs.com (NTBL)

Notable Labs, Ltd. (NTBL) is developing an IT solution for therapy selection while facing challenges related to clinical validation and partnership costs. Revenue is based on precision diagnostics of patient drug responses. The current pre-revenue stage and linear growth of expenses are hindering scalability. The company's commercial sales metric has reached 0.00, as clearly demonstrated by this chart.

NTBL Notable Labs Ltd: Company Sales in the range 02/21/2024 - 11/02/2024

Comprehensive metric breakdowns and analytics for Notable Labs Inc. (NTBL)

- market price and analyst price targets:
Comprehensive company analysis:Notable Labs, Ltd.
Core merchandise of Notable Labs Ltd

The retention of unique AI specialists and biologists at Notable Labs, Ltd. (NTBL) converts directly into the commercial value of developed therapies. This metric aggregates the total cash flow from service delivery, reflecting the efficiency of intellectual capital monetization through the volume of market transactions. An analysis of the company's sales profile allows for an assessment of the balance between operational income stability and the asset's capitalization growth potential.

Key competitors

Company Revenue ONC|Revenue and Sales Volume HALO|RVMD (Revolution Medicines, Inc.) - Company Sales Revenue|Company Revenue Ascentage Pharma Corp AAPG|Company Total Sales Volume CG Oncology, Inc.|URGN - Company Revenue|Bicara Therapeutics Inc. (BCAX) - Company Sales|Personalis Inc (PSNL) - Company Revenue|ERAS - Company Gross Revenue|DCTH (Delcath Systems Inc) - Revenue and Sales Volume|Company Revenue YMAB|Revenue and Sales Volume AURA|Company Revenue CADL (Candel)|Accuray, Inc. - Company Sales|SELLAS Life Sciences Group Inc. - Company Revenue|ACTU: Company Sales|Company Total Revenue Citius Oncology Inc|HURA: Revenue and Sales Volume|TARA: Company Total Sales|FATE (fatetherapeutics.com) - Revenue and Sales Volume|Company Sales Aadi Bioscience Inc (WHWK)|Revenue and Sales Volume TCRX|CSBR - Company Total Revenue|Revenue and Sales Volume XBIT (XBiotech Inc.)|CEL-SCI Corporation (CVM) - Company Total Revenue|OSTX: Company Sales|Company Sales Revenue RADX (Radiopharm Theranostics)|Artiva (ARTV) - Company Revenue|ANL: Company Total Sales|VERU (Veru Corporation) - Revenue and Sales Volume|Company Total Revenue Tempest Therapeutics, Inc. TPST|Revenue and Sales Volume XLO|Renovaro - Company Sales Volume|Company Revenue Mural Bio MURA|KAPA: Company Sales Volume|OnKure Therapeutics - Revenue and Sales Volume|Company Gross Revenue w2.cytomed.sg GDTC|CRIS: Revenue and Sales Volume|Company Sales Apollomics Inc.|THAR (Tharimmune Corporation) - Revenue and Sales Volume|Revenue and Sales Volume Advanced Biomed Inc|Revenue and Sales Volume GNPX|Company Sales Calidi Biotherapeutics Inc. CLDI|Company Revenue Sunshine Biopharma Inc. SBFM|Company Gross Revenue Xenetic Biosciences (XBIO)|SLRX - Company Revenue|Company Total Revenue Kitov Pharma|AON (AONC) - Company Revenue|Company Sales BeiGene|Company Revenue checkpointtx.com|Company Sales Volume ELEV (Elevation Oncology)|Revenue and Sales Volume ICAD|Ikena Oncology - Company Sales Volume|Company Revenue viracta.com VIRX|morphosys.com (MOR) - Company Total Revenue|NAYA Biosciences Inc - Revenue and Sales Volume|AAPGV: Company Revenue